Search for: "BRISTOL-MYERS SQUIBB COMPANY" Results 301 - 320 of 465
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
11 Jan 2013, 6:27 pm by Prashant Reddy
The patents for the remaining two drugs – Ixabepilone and Dastinib are owned by Bristol Myers Squibbs (BMS). [read post]
10 Apr 2015, 2:00 am
We reported to you last August on Bristol-Myers Squibb Co. v. [read post]
5 Apr 2011, 8:38 pm by Dale Carpenter
 to join Bristol Myers Squibb and GlaxoSmithKline in their efforts to prevent the illegal production of patented AIDS drugs in Africa? [read post]
9 Oct 2011, 4:35 pm by Lawrence B. Ebert
Merck, Johnson & Johnson, Eli Lilly and Bristol-Myers Squibb also cut jobs. [read post]
28 Mar 2008, 7:25 am
Proponents have withdrawn resolutions at Abbott Laboratories, Aetna, Bristol-Myers Squibb, Eli Lilly, General Electric, IBM, Johnson & Johnson, McDonald's, Medco, WellPoint, ExxonMobil, Merck, Target, and Waste Management after many of the companies agreed to post statements on health care reform on their Web sites. [read post]
23 Feb 2007, 8:46 am
In early 2005, the United Brotherhood of Carpenters and Joiners of America, the Sheet Metal Workers International Association, and other labor pension funds founded a work group with companies like Bristol-Myers Squibb, Cinergy, Time Warner, and Chevron to address majority voting in director elections. [read post]
14 Feb 2017, 8:05 am by Law Offices of Jeffrey S. Glassman
For this reason, sales of Eliquis, manufactured by Bristol Myers Squibb, are beginning to approach the numbers of Xarelto sales. [read post]
12 Sep 2019, 5:44 pm by Doyle, Barlow & Mazard PLLC
Francis Rooney (R-FL) wrote a letter to the FTC, urging the agency to investigate Bristol-Myers Squibb Company’s (“Bristol-Myers”) acquisition of Celgene Corporation (“Celgene”). [read post]
16 Sep 2016, 4:07 am by John Collins
Previously, the Full Court in Bristol-Myers Squibb Company v Apotex Pty Ltd [2015] FCAFC 2 (BMS) upheld Justice Yates’ ruling at first instance that the grant of an ‘exclusive licence’ meant an exclusive licence to undertake all of the activities within the meaning of “exploit” as defined in the Patents Act. [read post]
6 Dec 2011, 10:00 am by Lucas A. Ferrara, Esq.
  Erbitux is co-marketed by New York City-based Bristol-Myers Squibb and Eli Lilly and Company based in Indianapolis, Ind. [read post]
12 Mar 2010, 4:06 pm by Mark Zamora
Source:http://www.webmd.com/heart-disease/news/20100312/new-plavix-warning-lack-of-effect-in-gene-carriersAs far back as November 23, 1998 the Federal Drug Administration (FDA) expressed its concern with the claims made by the drug manufacturer, Bristol-Myers Squibb/Sanofi Pharmaceuticals about Plavix. [read post]
2 Nov 2015, 7:42 am by Altman & Altman
Its joint manufacturers, Pfizer and Bristol-Myers Squibb, have recently kicked off a targeted direct-to-consumer advertising campaign to market the drug for a-fib treatment as well as for newly approved uses. [read post]
17 Feb 2017, 12:21 pm by Amy Howe
Bristol-Myers Squibb Co. v. [read post]
19 Mar 2010, 1:22 am
Solomon, who co-chaired Proskauer's litigation practice until last year, will bring with him a roster of clients, including PepsiCo, Bristol-Myers Squibb and AriZona Iced Tea. [read post]
24 May 2012, 4:23 am by Max Kennerly, Esq.
Bristol-Myers Squibb Co., 2011 WL 2784101, at *3 (D.N.J. 2011), the Court did not hold that the warning label was enough to give notice. [read post]
27 May 2020, 3:03 am by Lynn Jokela
  Independent chair votes at pharmaceutical companies have received significant support (based on For/For + Against), including: 42% at J&J, where the vote had been increasing in recent years and where there was majority support for another IOPA proposal requesting a board report on governance of opioid-related risks; 34% at Eli Lilly, where it was a first-time proposal and where the vote would be 40% if the Lilly Endowment shares were backed out; 44.5% at… [read post]
20 Jan 2010, 10:36 am by Ted Allen
In addition, Time Warner, Genzyme, Bristol-Myers Squibb, International Paper, Pinnacle West Capital, and Liz Claiborne Inc. have filed similar no-action requests to exclude proposals with a 10 percent threshold, according to investors. [read post]